Investing In DENTSPLY Sirona Inc (NASDAQ: XRAY): Why Should You?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Medical Instruments & Supplies industry segment. The current market capitalization of DENTSPLY Sirona Inc is $3.91B. A total of 1.29 million shares were traded on the day, compared to an average of 3.05M shares.

In the most recent transaction, LUCIER GREGORY T bought 5,000 shares of XRAY for 18.37 per share on Nov 18 ’24. After the transaction, the Director now owns 71,730 company shares. In a previous transaction on Nov 15 ’24, LUCIER GREGORY T bought 1,000 shares at 18.28 per share. XRAY shares that Director owns now total 16,000.

Among the insiders who bought shares, Campion Simon D acquired of 11,306 shares on Nov 12 ’24 at a per-share price of $17.72. This resulted in the President, CEO & Member of BOD holding 272,247 shares of XRAY after the transaction. In another insider transaction, LUCIER GREGORY T bought 8,212 shares at $24.35 per share on Aug 08 ’24. Company shares held by the Director now total 66,661.

Dividend

The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. XRAY’s most recent ex-dividend date was 9/27/2024 when it declared a $0.16 quarterly dividend that was paid in cash on 10/11/2024. Previously, the company paid the dividend on 7/12/2024 with an ex-dividend date of 6/28/2024. The XRAY stock dividend was $0.16 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, XRAY has a high of $37.60 and a low of $17.21.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. XRAY’s latest balance sheet shows that the firm has $339.00M in Cash & Short Term Investments as of fiscal 2021. There were $2.29B in debt and $1.26B in liabilities at the time. Its Book Value Per Share was $12.53, while its Total Shareholder’s Equity was $5.00B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XRAY is Buy with a score of 3.86.

Most Popular

Related Posts